Skip to content

Clinical trials

Phase 1 Glioblastoma trials in the Netherlands

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Glioblastoma Phase: Phase 1 Country / region: Netherlands Clear all

20 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20091
20122
20141
20151
20161
20171
20183
20201
20211
20234
20242
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed10
Recruiting3
Terminated3
Active, not recruiting2
Unknown status2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals3
European Organisation for Research and Treatment of Cancer - EORTC2
Maastricht Radiation Oncology2
Amgen1
C.Dirven1
Celgene1
CureVac1
Immatics Biotechnologies GmbH1
Kartos Therapeutics, Inc.1
M.E. van Linde1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Glioblastoma20
Glioma6
Astrocytoma3
Neoplasms3
Central Nervous System Neoplasms2
Esophageal Neoplasms2
Pancreatic Neoplasms2
Stomach Neoplasms2
Breast Neoplasms1
Carcinoma, Non-Small-Cell Lung1

Trials

Showing 1 to 20 of 20. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.